Jean-Paul Clozel

Article Abstract:

Jean-Paul Clozel, the CEO of Switzerland's largest biotech firm, Actelion Pharmaceuticals, owes his success to the drug Tracleer, a treatment for pulmonary arterial hypertension. This disease affects 145,000 people in the U.S. and Europe and the product had sales exceeding $480 million in 2005 across more than 30 countries. Due to Clozel's ultimate dream of discovering new drugs, he went on to co-found Actelion.

Pharmaceutical Preparation Manufacturing, Market share, Pharmaceutical preparations, Executive changes & profiles, Blood Pressure Preparations, Officials and employees, Switzerland, Beliefs, opinions and attitudes, Antihypertensive drugs, Antihypertensive agents, Company market share, Actelion AG, Tracleer (Medication), Clozel, Jean-Paul

---

Fighting company spin

Article Abstract:

A few indicators that can signal whether the company uses or abuses the most important press releases such as the ones that appear at quarterly or annual earnings time are discussed. Many companies disseminate press releases most commonly online through BusinessWire or PR Newswire.

United States, Press conferences

---

Biotech at the beauty counter

Article Abstract:

More and more biotech companies are making profit by entering the cosmeceutical sector due to increase in consumer demand.

United Kingdom

Similar abstracts:

• Abstracts: Tweedie's best of breed. Otty the younger. Nick Land loses office
• Abstracts: Diversifying in biotech. Does biotech M&A benefit investors?. Biotech IPOs: handle with care
• Abstracts: Three US states launch biotech seed funds. Global biotech expansion taking cues from Bayh-Dole. Unlocking the money-making potential of RNAi
• Abstracts: Insect resistance management in GM crops: Past, present and future. Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution
• Abstracts: Materials exchange deal meager boost to India's biotech. U.S. biodefense-shocking and awful. US food aid still under GM cloud

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.